Summary by Moomoo AI
PHARMA MING BIOTECHNOLOGY CO., LTD. FILED A NEXT DAY DISCLOSURE REPORT ON MAY 14, 2024 DISCLOSING SHARE REPURCHASE ACTIVITIES FOR THE PERIOD FROM DECEMBER 7, 2023 TO MAY 14, 2024. The company has made several share repurchases during this period, but has not written them off. The last repurchase took place on 14 May 2024. The number of shares repurchased was 2,725,000 shares at a repurchase price range of HK$14.42 to HK$15 per share for a total payment of HK$39,863,230. Since the adoption of the Ordinary Resolution, the total number of securities repurchased by the Company on the Hong Kong Stock Exchange has reached 102,968,000 shares, representing 2.42368% of the issued shares. According to the report, all repurchases comply with the relevant provisions of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.